11-62605950-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153265.3(EML3):āc.1687A>Gā(p.Ile563Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000128 in 1,614,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_153265.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EML3 | NM_153265.3 | c.1687A>G | p.Ile563Val | missense_variant | 14/22 | ENST00000394773.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EML3 | ENST00000394773.7 | c.1687A>G | p.Ile563Val | missense_variant | 14/22 | 1 | NM_153265.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000163 AC: 41AN: 251240Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135820
GnomAD4 exome AF: 0.000129 AC: 188AN: 1461848Hom.: 0 Cov.: 31 AF XY: 0.000132 AC XY: 96AN XY: 727228
GnomAD4 genome AF: 0.000125 AC: 19AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2023 | The c.1687A>G (p.I563V) alteration is located in exon 14 (coding exon 14) of the EML3 gene. This alteration results from a A to G substitution at nucleotide position 1687, causing the isoleucine (I) at amino acid position 563 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at